▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1279 by analyst upside · 2026-09-27
FENC
Fennec Pharmaceuticals Inc.
Healthcare · Market Cap $372M · P/E 0x
ANALYST PRICE TARGET
+66.6%
implied upside to consensus target
Current Price $10.61
Consensus Target $17.67
Bull Target $20.0
Bear Target $16.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
0
Sell
0
52-Week Low $5.65
52-Week High $13.25
YTD Return +38.1%
FUNDAMENTALS
Market Cap $372M
P/E Ratio (TTM) N/A
Forward P/E 11.2x
EPS (TTM) $-0.12
PEG Ratio 1.47
Dividend Yield N/A
Revenue (TTM) $59M
Profit Margin -5.5%
52-WEEK RANGE
52-Week Low $5.65
52-Week High $13.25
Current Price $10.61
Bear Target $16.0
Bull Target $20.0
● Now $10.61 ● Target $17.67
TRADING DATA
Avg Volume 201K
YTD Return +38.1%
Analyst Count 6
Consensus Buy
Upside to Target +66.6%
Last Updated 2026-09-27

ANALYST SUMMARY

Fennec Pharmaceuticals Inc. (FENC) is currently trading at $10.61 with a Wall Street consensus price target of $17.67, implying potential upside of 66.6% over the next 12 months. 6 analysts currently cover FENC, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $20.0, while the most cautious has a target of $16.0.

FENC operates in the Healthcare sector with a market capitalisation of $372M. The stock is up 38.1% year-to-date and is currently trading near the upper end of its 52-week range of $5.65 – $13.25.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

VMD +40.3%
Viemed Healthcare, Inc.
$339M · P/E 24.7x · Buy
CGEN +93.3%
Compugen Ltd.
$225M · P/E 6.3x · Buy
CYH +7.4%
Community Health Systems, Inc.
$415M · P/E 1.7x · Hold
KMDA +54.8%
Kamada Ltd.
$503M · P/E 22.9x · Buy
INFU +32.4%
InfuSystem Holdings, Inc.
$253M · P/E 31.8x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for FENC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. reit
Buy → Buy 2026-09-09 31% win rate (48 calls)
B. Riley Securities reit
Buy → Buy 2026-08-12 17% win rate (6 calls)
Wedbush - Reiterated
Outperform → Outperform 2026-08-12 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-05-22 31% win rate (48 calls)
Wedbush reit
Outperform → Outperform 2026-04-16 Building track record
Piper Sandler ● Initiated
Overweight 2026-01-09 14% win rate (7 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-08-21 31% win rate (48 calls)
Craig-Hallum - Reiterated
Buy → Buy 2025-08-15 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
64
out of 100
Coverage depth
15/30
Consensus clarity
22/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →